# The Effect of Sitagliptin, Pioglitazone and Dapagliflozine on Myocardial Infarction in Diabetic Rats

> **NCT07083232** · PHASE4 · COMPLETED · sponsor: **Al-Azhar University** · enrollment: 50 (actual)

## Conditions studied

- Diabetic
- Myocardial Infarction

## Interventions

- **DIETARY_SUPPLEMENT:** standard normal diet
- **DRUG:** low dose Streptozotocin
- **DRUG:** Sitagliptin (Novartis, USA)
- **DRUG:** Pioglitazone hydrochloride (Unipharma., Egypt)
- **DRUG:** Dapagliflozine hemihydrate (Janssen, USA)

## Key facts

- **NCT ID:** NCT07083232
- **Lead sponsor:** Al-Azhar University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-30
- **Primary completion:** 2024-10-30
- **Final completion:** 2024-11-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07083232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07083232, "The Effect of Sitagliptin, Pioglitazone and Dapagliflozine on Myocardial Infarction in Diabetic Rats". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07083232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*